Replies to post #171637 on Amarin Corp Plc (AMRN)

[massulo52]

I like it. Thanks

[Biobillionair]

What a completely inaccurate article.

Amarin is predicting revenues of $224m to $228m this year and says the REDUCE-IT data could push its top-line up more than 50% to $350m or so this year. Analysts at Jefferies think the product could bring in $2bn at peak, so it will be interesting to see how much Pfizer might be prepared to pay for that potential.

Amarin "guided" $350m and did not include additional speculation on what extra a R-I label could bring.

$2 Billion in peak sales...Duh!!! This would mean horrible penetration for a cardiovascular drug that further reduces events by 25% on top of best current treatment. Medical malpractice lawsuits would run rampant.

This M&A crap is already getting annoying.

BB